Form 4: Procter & Gamble Director Joseph Jimenez Reports Acquisition of Common Stock
SEC Form 4 Filing
Director Joseph Jimenez reports acquiring 268 shares of Procter & Gamble common stock through restricted stock units.
Summary
- On September 10, 2024, Joseph Jimenez, a director of Procter & Gamble, reported acquiring 268 shares of common stock.
- The acquisition was through the award of Restricted Stock Units (RSUs) under the company's 2019 Stock and Incentive Compensation Plan.
- The price per share for the acquisition is reported as $0.
- Following the transaction, Jimenez beneficially owns 31,154.5277 shares of Procter & Gamble common stock, including dividend equivalents in the form of RSUs.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports a standard transaction. The acquisition of shares by a director is generally viewed positively, but the impact is likely minimal.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's view of the company's prospects.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- It provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 09/10/2024 | Date of transaction: Joseph Jimenez acquired common stock. |
| 09/11/2024 | Date of signature: Form 4 signed by attorney-in-fact for Joseph Jimenez. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.